Ongoing Urologic Cancer Research
The University of Chicago Medicine has a rich tradition of research in urologic cancer. In fact, our first chief of urology, the late Dr. Charles B. Huggins, shared the Nobel Prize in Medicine in 1966 for research that led to the discovery of hormonal therapy for prostate cancer.
Today, our physicians and researchers continue to improve the treatment of patients with cancer. We focus on our patients, and how we, as physicians and scientists, can improve their lives.
Our urology translational research program is a particularly exciting initiative. In translational research, our physicians and laboratory researchers work hand-in-hand to provide patients with the newest, most promising treatments as quickly as possible. In one example, we are researching drugs designed to kill tumors by choking off their blood supply. We are also working on an anti-cancer vaccine for kidney cancer patients.
Participate in a Clinical Trial
University of Chicago Medicine physicians offer access to clinical trials of promising new drugs and treatments not widely available.